Table 3.
1st phase | 2nd phase | ||||
Treatment | Dose (mg/Kg) | Median | % | Median | % |
Control | - | 58.5 | - | 36 | - |
Morphine (i.p.) | 7.5 | 10.5a | 87 | 0a | 81.8 |
AE (p.o.) | 100 | 45 | 38 | 16 | 28.5 |
AE (p.o.) | 200 | 43 | 43.1 | 6a | 49.3 |
AE (p.o.) | 400 | 38 | 43.1 | 1a | 53.7 |
Morphine (i.p.)+Naloxone (i.p.) | 5 | 55.5 | 16.5 | 18a | 33.8 |
Naloxone (i.p.)+AE400 | 5 | 37a | 62.8 | 3a | 71.4 |
Caffeine (i.p.)+AE400 | 10 | 44a | 55 | 26.5 | 19.8 |
%, pain reaction time inhibition percentage. ap < 0.05 compared to control (Kruskal-Wallis, followed by Nemenyi), AE400, aqueous extract 400 mg/Kg.